RenaSci

Abuse & Dependence

Abuse and dependence testingRenaSci is a leading provider of consultancy and experimental services to evaluate the abuse/dependence liability of novel CNS drugs. We offer the complete package of preclinical models that are mandatory testing procedures for the regulatory approval of centrally-acting drugs together with the expertise to prepare all of the associated regulatory documents. Our experimental studies and reports and our regulatory expertise have provided our clients with many successful USA and European drug approvals. RenaSci is also a founding member and integral part of ALTeC Abuse Liability Testing Collaboration which offers a unique “one-stop shop” for abuse liability testing services in animals and man. ALTeC facilitates drug development by working closely with your representatives and the regulatory authorities to perform an appropriate and efficient abuse liability evaluation and optimum Controlled Drug labelling.

Our preclinical models for assessing abuse/dependence liability can also be used to evaluate novel treatments for drug dependence (addiction).

We offer abuse-related non-clinical studies to GLP.

Leaflets